Back to Agenda
Looking forward to this session? Share it!
- Factors leading to the increased need and utilization of RWD
- The 21st Cure Act of Congress and FDA’s mandate to develop RWE program for drug development
- Types and roles of RWD in the drug development life cycle: past and present
- How we are currently able to leverage RWE to inform clinical trials by phase
- Example for leveraging RWE to inform and support clinical trials
- Current limitations of RWD and RWE